RxDoctor Payments Data

James Kemper, MD

Otology & Neurotology · Austin, TXNPI 1568450948

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Cochlear Americas at 33.8% of the total. Reporting peaked in 2020 at $272 and has fallen 88.8% since, to $31 in 2025. That places this record below the midpoint for otology & neurotology clinicians in TX, where the typical reported total is $1,716.

$1,097in general payments, 2019–2025

Across 21 payments — averaging $52.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$371
  • Advanced Bionics, LLC$300
  • Olympus America Inc.$141
  • Medtronic$111
  • Johnson & Johnson$109
  • Sanofi$31
  • plus $36 from 2 others
$644in research payments, 2019–2025

Across 2 payments — averaging $322.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Advanced Bionics, LLC$644

What the payments were for

  • Food & beverage$1,097100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,097 in reported general payments places this provider in the 35th percentile of 33 otology & neurotology providers in Texas.

See all otology & neurotology providers in Texas

Medicare billing

Part B allowed, 2024
$110,492
Medicare patients
331
Services billed
1,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Potassium Chloride141$2,232
Hydrochlorothiazide386$1,818
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth14$1,386
Ofloxacin46$1,353
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort15$898
Doxepin Hcl34$843
Acetazolamide21$692
Montelukast Sodium30$328
Mometasone Furoate20$312
Klor-Con 8Potassium Chloride17$311
Spironolactone25$244
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid21$239
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$236
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$195
Prednisone34$133

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →